Merck & Company: Product KL-798
通常価格
¥1,012 JPY
通常価格
セール価格
¥1,012 JPY
単価
あたり
Merck has been approached by a small biotech research firm with the proposal that Merck buy the rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of phase I of the FDA approval process. Pat Harlow, the chief licensing officer, has been leading Merck's investigation team. A meeting is scheduled for tomorrow at which Merck's response to the offer will be drafted.
【書誌情報】
ページ数:4ページ
サイズ:A4
商品番号:HBSP-UV3844
発行日:2002/7/9
登録日:2016/9/6